Inventor · disambiguated record
Stephan Schilling
Also filed as: SCHILLING STEPHAN
32 granted patents·20 pending applications·373 citations·filing 2004–2025
96Inventor score
Files withPROBIODRUG AG27SCHILLING STEPHAN8DEMUTH HANS-ULRICH5VIVORYON THERAPEUTICS N V4GRAUBNER SIGRID2
Top patents by PatentIndex Score
52 records- 0197US7732162B2Inhibitors of glutaminyl cyclase for treating neurodegenerative diseasesPROBIODRUG AG·Filed 2007·Granted Jun 8, 2010·51 cites·19 claims
- 0296US7371871B2Inhibitors of glutaminyl cyclasePROBIODRUG AG·Filed 2004·Granted May 13, 2008·90 cites·20 claims
- 0396US7304086B2Inhibitors of glutaminyl cyclasePROBIODRUG AG·Filed 2005·Granted Dec 4, 2007·64 cites·38 claims
- 0494US7381537B2Use of inhibitors of glutaminyl cyclases for treatment and prevention of diseasePROBIODRUG AG·Filed 2004·Granted Jun 3, 2008·62 cites·27 claims
- 0592US8058405B2Antibodies specific for N-terminal truncated and pyroglutamate modified amyloid-beta peptidesDEMUTH HANS-ULRICH·Filed 2009·Granted Nov 15, 2011·38 cites·28 claims
- 0689US7462599B2Use of effectors of glutaminyl and glutamate cyclasesPROBIODRUG AG·Filed 2004·Granted Dec 9, 2008·31 cites·14 claims
- 0785US10603367B2Humanized antibodiesPROBIODRUG AG·Filed 2018·Granted Mar 31, 2020·2 cites·18 claims
- 0885US8129160B2Method of screening for inhibitors of glutaminyl cyclase activitySCHILLING STEPHAN·Filed 2009·Granted Mar 6, 2012·7 cites·19 claims
- 0984US8338120B2Method of treating inflammation with glutaminyl cyclase inhibitorsSCHILLING STEPHAN·Filed 2008·Granted Dec 25, 2012·5 cites·16 claims
- 1081US8409837B2Crystal structure of glutaminyl cyclaseSCHILLING STEPHAN·Filed 2011·Granted Apr 2, 2013·5 cites·8 claims
- 1180US8283517B2Transgenic mouse models of Aβ overexpressionSCHILLING STEPHAN·Filed 2008·Granted Oct 9, 2012·6 cites·29 claims
- 1279US8809010B2Method for prophylactic treatment of alzheimer's disease using inhibitors of glutaminyl cyclase and glutamate cyclasesHOFFMANN TORSTEN·Filed 2009·Granted Aug 19, 2014·3 cites·13 claims
- 1378US8889709B2Use of isoQC inhibitors in the treatment and prevention of inflammatory diseases or conditionsDEMUTH HANS-ULRICH·Filed 2009·Granted Nov 18, 2014·4 cites·37 claims
- 1477US7655684B2Inhibitors of glutaminyl cyclasePROBIODRUG AG·Filed 2008·Granted Feb 2, 2010·2 cites·18 claims
- 1572US2025388544A1Heteroaromatic inhibitors of astacin proteinasesVIVORYON THERAPEUTICS N V·Filed 2025·Application pending·0 cites
- 1670US8647834B2Screening method for enzyme inhibitorsSCHILLING STEPHAN·Filed 2011·Granted Feb 11, 2014·2 cites·19 claims
- 1769US2010028918A1Glutaminyl cyclase as a diagnostic/prognostic indicator for neurodegenerative diseasesPROBIODRUG AG·Filed 2009·Application pending·0 cites
- 1867US11045533B2Humanized antibodiesPROBIODRUG AG·Filed 2020·Granted Jun 29, 2021·0 cites·18 claims
- 1966US12378186B2Inhibitors of meprin α and βVIVORYON THERAPEUTICS N V·Filed 2021·Granted Aug 5, 2025·0 cites·19 claims
- 2061US8809508B2Diagnostic antibody assayKLEINSCHMIDT MARTIN·Filed 2012·Granted Aug 19, 2014·1 cites·10 claims
- 2161US8685664B2Use of inhibtors of glutaminyl cyclases for treatment and prevention of diseaseDEMUTH HANS-ULRICH·Filed 2008·Granted Apr 1, 2014·0 cites·16 claims
- 2260US9462793B2Mouse carrying a knock-out mutation of the Qpct-geneSCHILLING STEPHAN·Filed 2009·Granted Oct 11, 2016·0 cites·37 claims
- 2360US2010159032A1Combinations useful for the treatment of neuronal disordersPROBIODRUG AG·Filed 2009·Application pending·0 cites
- 2459US8518406B2Antibodies directed against pyroglutamate monocyte chemoattractant protein-1 (MCP-1 N1pE)CYNIS HOLGER·Filed 2009·Granted Aug 27, 2013·0 cites·26 claims
- 2559US8470781B2Use of effectors of glutaminyl and glutamate cyclasesSCHILLING STEPHAN·Filed 2008·Granted Jun 25, 2013·0 cites·13 claims
- 2659US2008249083A1Novel genes related to glutaminyl cyclasePROBIODRUG AG·Filed 2007·Application pending·0 cites
- 2757US9157918B2Antibodies directed against pyroglutamate monocyte chemoattractant protein-1 (MCP-1 N1pE)PROBIODRUG AG·Filed 2013·Granted Oct 13, 2015·0 cites·7 claims
- 2857US7897633B2Inhibitors of glutaminyl cyclasePROBIODRUG AG·Filed 2007·Granted Mar 1, 2011·0 cites·23 claims
- 2957US2023122243A1Heteroaromatic inhibitors of astacin proteinasesVIVORYON THERAPEUTICS N V·Filed 2020·Application pending·0 cites
- 3057US2017097365A1Glutaminyl cyclase as a diagnostic/prognostic indicator for neurodegenerative diseasesPROBIODRUG AG·Filed 2016·Application pending·0 cites
- 3154US9657089B2Diagnostic antibody assayPROBIODRUG AG·Filed 2014·Granted May 23, 2017·0 cites·20 claims
- 3254US8859250B2Crystal structure of glutaminyl cyclasePROBIODRUG AG·Filed 2013·Granted Oct 14, 2014·0 cites·13 claims
- 3353US2015247180A1Glutaminyl cyclase as a diagnostic/prognostic indicator for neurodegenerative diseasesPROBIODRUG AG·Filed 2015·Application pending·0 cites
- 3453US2005171112A1Combinations useful for the treatment of neuronal disordersPROBIODRUG AG·Filed 2004·Application pending·0 cites
- 3552US9156907B2Diagnostic antibody assayDEMUTH HANS-ULRICH·Filed 2011·Granted Oct 13, 2015·0 cites·50 claims
- 3649US12043659B2Humanized and de-immunized antibodiesVIVORYON THERAPEUTICS N V·Filed 2019·Granted Jul 23, 2024·0 cites·14 claims
- 3748US9676843B2Uses of antibodies directed against amyloid-βPROBIODRUG AG·Filed 2015·Granted Jun 13, 2017·0 cites·26 claims
- 3846US2015361167A1Antibodies directed against pyroglutamate monocyte chemoattractant protein-1 (mcp-1 n1pe)PROBIODRUG AG·Filed 2015·Application pending·0 cites
- 3946US2005137142A1Combinations useful for the treatment of neuronal disordersPROBIODRUG AG·Filed 2004·Application pending·0 cites
- 4045US2008200567A1In vivo screening models for treatment of alzheimer's disease and other qpct-related disordersPROBIODRUG AG·Filed 2008·Application pending·0 cites
- 4144US11703511B2Anti-isoAsp7 amyloid β (Aβ) antibodies and uses thereofFRAUNHOFER GES FORSCHUNG·Filed 2018·Granted Jul 18, 2023·0 cites·16 claims
- 4244US2004229848A1Glutaminyl based DP IV-inhibitorsDEMUTH HANS-ULRICH·Filed 2004·Application pending·0 cites
- 4343US9277737B2Mouse models carrying a knock-out mutation of the QPCTL-genePROBIODRUG AG·Filed 2013·Granted Mar 8, 2016·0 cites·19 claims
- 4441US8741614B2Crystal structure of isoglutaminyl cyclaseSTEPHAN ANETT·Filed 2011·Granted Jun 3, 2014·0 cites·10 claims
- 4541US2012070444A1IN VIVO SCREENING MODELS FOR TREATMENT OF isoQC-RELATED DISORDERSGRAUBNER SIGRID·Filed 2011·Application pending·0 cites
- 4638US2017363645A1Novel Method for the Detection of pGlu-Abeta PeptidesPROBIODRUG AG·Filed 2015·Application pending·0 cites
- 4738US2012184518A1Methods of treating or preventing an inflammatory disease or condition using glutaminyl cyclase inhibitorsSCHILLING STEPHAN·Filed 2012·Application pending·0 cites
- 4837US2015150225A1Transgenic mouse expressing human isoglutaminyl cyclotransferasePROBIODRUG AG·Filed 2015·Application pending·0 cites
- 4937US2011152341A1Cleavage of b-amyloid precursor proteinPROBIODRUG AG·Filed 2010·Application pending·0 cites
- 5035US2018228825A1Sulfolipids as new glutaminyl cyclase inhibitorsHOCHSCHULE ANHALT·Filed 2016·Application pending·0 cites
Showing the top 50 of 52 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Stephan Schilling files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →